Table 1.

Degree of coverage of RA elements with pathways vulnerable to AFlut for different substrates and antiarrhythmic drugs amiodarone (amio) and dronedarone (drone).

	Degree of coverage
	Original CV			Total activation time matched
	no drug	amio	drone	no drug	amio	drone
Control	18.1%	70.5%	0.0%	18.1%	0.0%	0.0%
cAF	96.0%	96.3%	95.6%	96.2%	96.1%	94.9%
N588K	93.2%	94.1%	0.0%	93.0%	77.8%	0.0%
L532P	96.2%	96.5%	34.5%	96.3%	96.0%	11.1%

In the right three columns, the A and B values determining the CV according to Equation (3) were scaled to match the activation time of the last element during sinus rhythm in the control substrate with no drug applied.